Why Albireo Pharma Shares Moving Higher Today?
Albireo Pharma Inc (NASDAQ:ALBO) entered into a royalty monetization agreement with Sagard Healthcare Partners for $115 million in return for a…
Novo Nordisk’s Experimental Diabetes Treatment Achieves Better Blood Sugar Targets Than Insulin Degludec
Novo Nordisk A/S (NYSE:NVO) presented new data from the phase 3a ONWARDS 2 trial of insulin icodec in type 2 diabetes…
BARDA Exercises First Contract Option With Marinus Pharma For Its Epilepsy Candidate
Marinus Pharmaceuticals Inc (NASDAQ:MRNS) announced that the Biomedical Advanced Research and Development Authority (BARDA) exercised its first contract option,…
Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries
Pfizer Inc (NYSE:PFE) would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low-…
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
Better Therapeutics Inc (NASDAQ:BTTX) has submitted a de novo classification request to the FDA seeking approval for BT-001 digital therapeutic designed to…
FDA Approves Lilly’s Retevmo, the First and Only RET Inhibitor For Solid Tumor Indications
The FDA has approved Eli Lilly And Co’s (NYSE:LLY) Retevmo (selpercatinib, 40 mg & 80 mg capsules) for solid tumors. The…
Why Are Plus Therapeutics Shares Gaining Today?
Plus Therapeutics Inc (NASDAQ:PSTV) has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT)…
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell carcinoma that is resistant to prior immunotherapy.
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
Novartis AG (NYSE:NVS) has revealed insights into the updated company strategy. The company said that a ‘US-first’ mindset, increasing the…